Intravascular Catheters Market Set for Strong Growth to USD 14.44 Billion by 2031, Led by North America's 38% Global Market Share | DataM Intelligence

The Global Intravascular Catheters Market reached USD 7.78 billion in 2023 and is expected to reach USD 14.44 billion by 2031, growing at a strong CAGR of 8.1% during 2024-2031.

Market growth is driven by the rising prevalence of cardiovascular diseases, increasing number of surgical and interventional procedures, and growing demand for minimally invasive treatment options. Additionally, advancements in catheter design, improved biocompatible materials, and expanding healthcare infrastructure in emerging economies are further supporting market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/intravascular-catheters-market?ram

United States: Key Industry Developments
✅ June 2025: Stryker launched the AXS Lift Intracranial Base Catheter, designed to simplify neurovascular access and provide stable support from groin puncture to the cavernous segment of the internal carotid artery for complex procedures.​

✅ March 2025: Shockwave Medical, part of Johnson & Johnson MedTech, introduced the Shockwave Javelin Peripheral IVL Catheter in the U.S., enabling safe modification and crossing of calcified lesions in peripheral artery disease patients.​

Asia Pacific / Japan: Key Industry Developments
✅ November 2025: Japan's peripherally inserted central catheter (PICC) market demand reached USD 50.7 million, driven by aging population needs and shift to outpatient infusion therapies for chronic conditions like cancer.​

✅ September 2025: Johnson & Johnson announced the launch of Shockwave Javelin Peripheral IVL Catheter in Europe, with implications for Asia Pacific expansion in treating calcium-modified narrowed vessels for PAD.​

✅ June 2025: Asia Pacific led growth in IVUS catheters market due to rising cardiovascular disease prevalence, healthcare spending, and tech advancements, particularly in China and India.​

Key Merges and Acquisitions(2025):
✅ Stryker Corporation acquired Inari Medical, Inc. for USD 4.9 billion in February 2025, strengthening its peripheral vascular position and enabling advanced treatments for venous thromboembolism clots in the intravascular catheters space.​

✅ Becton, Dickinson and Company (BD) purchased the Critical Care product line from Edwards Lifesciences for USD 4.2 billion in September 2024, adding Swan-Ganz pulmonary artery catheters to enhance BD's smart connected care solutions relevant to intravascular applications.

Market Segmentation Analysis:
-By Product Type: Short PIVC Leads with Dominant Share
Short PIVC holds 68% market share in 2018 (USD 2.8 billion revenue), driven by lower infection risks and high demand in surgical diagnostics for cardiovascular and neurological conditions.​
Integrated/Closed PIVC captures the remaining 32%, offering safety features like reduced needlestick injuries but growing slower due to higher costs.​

-By Application Type: Others Segment Dominates Usage
Others (including cardiovascular, urological, and trauma surgeries) commands 42% market share (USD 1.7 billion in 2018), fueled by broad surgical applications across multiple diseases.​
Oncology, Gastroenterology, Renal Disease, and Infectious Diseases split the rest, with oncology rising due to chemotherapy needs and renal from dialysis trends.​

-By End-User: Hospitals Hold Clear Majority
Hospitals lead with 57% market share (USD 2.5 billion in 2018), owing to high-volume procedures for cardiology, gastroenterology, and infections.​
Ambulatory Surgery Clinics, Clinics, Homecare, and Others account for 43%, with ambulatory centers growing via outpatient shifts.​

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=intravascular-catheters-market?ram (Purchase 2 or more Reports and get 50% Discount)

Growth Drivers:
-Rising prevalence of cardiovascular diseases and chronic conditions like cancer and diabetes, necessitating frequent diagnostic and therapeutic vascular access.​

-Expanding aging global population, which increases the need for minimally invasive interventions and long-term catheter use.​

-Technological advancements in catheter design, including smart sensors, novel biomaterials, and AI-integrated navigation for better precision and reduced complications.​

-Growing preference for minimally invasive procedures and outpatient surgeries, boosting demand for short-term and advanced catheter systems.​

-Healthcare infrastructure expansion and rising expenditures in emerging economies, alongside favorable reimbursement policies in developed regions.​

Regional Insights:
-North America leads the Intravascular Catheters Market with the highest share, estimated at around 38% in recent assessments, driven by advanced healthcare infrastructure, high prevalence of chronic diseases like cardiovascular conditions, and robust regulatory approvals for innovative devices.​

-Europe follows with approximately 28% market share, supported by strong demand in countries such as Germany, France, and the UK, where increasing surgical procedures and an aging population fuel adoption of intravascular catheters.​

-Asia Pacific holds about 26% share, exhibiting the fastest growth due to rapid healthcare expansion, rising chronic disease incidence in populous nations like China and India, and growing medical tourism.​

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/intravascular-catheters-market?ram

Key Players:
Omron Corporation | Koninklijke Philips N.V. | Cook Medical | Allied Healthcare Products, Inc. | Becton, Dickinson and Company | Agilent Technologies | Medline Industries, Inc. | Boston Scientific Corporation | Johnson & Johnson | GF Health Products, Inc.

Key Highlights (Top 5 Key Players) for Intravascular Catheters Market:
-Boston Scientific Corporation reported USD 1.2 billion in intravascular catheters and vascular intervention revenues in 2023, driven by strong demand for peripheral intervention catheters amid rising cardiovascular procedures.​

-Johnson & Johnson generated USD 950 million from its Cordis intravascular catheter portfolio in 2023, with growth fueled by innovations in diagnostic and guiding catheters for complex PCI cases.​

-Medtronic Inc. achieved USD 1.1 billion in catheter-based revenues for cardiovascular applications in 2023, bolstered by expansions in coronary and peripheral vascular segments.​

-Becton, Dickinson and Company recorded USD 850 million in vascular access catheter sales in 2023, including short peripheral IV catheters which held a dominant market share.​

-Cook Medical contributed USD 700 million to the market through its specialized interventional catheters in 2023, focusing on oncology and infectious disease applications with high growth potential.​

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.